Improving Lives Through Food for Education
Since 2013, AIR has conducted over 25 evaluations of McGovern-Dole Food for Education projects around the world. Through the program, the USDA provides support to low-income, food-deficit countries around the globe.
Using Evidence to Improve Outcomes and Inspire Behavior Change
Explore how AIR works with our partners in the field to help them use evidence to foster collaboration, strengthen system capacity, and provide equitable access to resources and opportunities.
Our mission is to generate and use rigorous evidence that contributes to a better, more equitable world.
Learn about our values, our history, and our commitment to diversity, equity, and inclusion.
AIR Equity Initiative
AIR is making a five-year, $100M+ investment in behavioral and social science research and technical assistance to address the underlying causes of systemic inequities and increase opportunities for people and communities.
LEARN MORE ABOUT THE INITIATIVE
READ THE EQUITY INITIATIVE'S ANNUAL REPORT (2021-22)
Spotlight on Our Work
Research & Program Evaluation
AIR conducts rigorous research and evaluations that provide important information about the effectiveness of programs and policies in the U.S. and across the globe.
We work shoulder-to-shoulder with clients to help them build capacity and transform systems to achieve better outcomes for those they serve.
Data Science and Technology
AIR uses data and technology to help our clients and communities identify challenges, find solutions, and make information usable and easily accessible.
Survey Design and Administration
Our experts can help government agencies and organizations develop, administer, and analyze surveys that create reliable, actionable data.
Research Insights on Health Equity for Afghan Refugees
Backed by the AIR Equity Initiative, AIR is working with partners to help multisector organizations collaborate more effectively and advance health equity for Afghan refugees. In this Q&A, AIR researchers Trenita Childers and Maliha Ali share early insights from the Health Equity for Afghan Refugees (HEAR) project in the District of Columbia, Maryland, and Virginia region.
Could Biosimilars Help Rein in Prescription Drug Costs?
Biologics are innovative therapies for people with debilitating and life-threatening diseases, but these drugs are expensive. In this Q&A, Thiyagu Rajakannan explains how lower-cost versions of these drugs and promising market, regulatory, and policy developments could ease the financial burden.